CPT® Code 38211

The procedure described by CPT® Code 38211 involves the preparation of hematopoietic progenitor cells, which are essential components used in stem cell transplantation. These cells are typically harvested from a patient or a donor and are preserved using a cryoprotectant solution to maintain their viability during storage at low temperatures. The primary goal of this procedure is to treat these harvested cells to ensure they are safe and effective for reinfusion into the patient. Specifically, this code is utilized when there is a need to deplete tumor cells from the harvested progenitor cells. This step is crucial as it helps to prevent the reinfusion of any malignant cells that could lead to disease recurrence. The process of tumor cell depletion enhances the overall safety and efficacy of the transplantation by ensuring that only healthy progenitor cells are administered back to the patient. This procedure is a vital part of the preparatory phase before the actual transplantation occurs, ensuring that the patient receives the best possible outcome from the stem cell transplant.